Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Accounting Policies [Abstract] | |||
| Restricted cash | $ 0.9 | $ 0.9 | $ 0.9 |
| Reimbursement of research and development expenses | 4.3 | 4.3 | |
| Reimbursement of research and development expenses, received | 3.0 | 3.0 | |
| Reimbursement of research and development expenses, receivable | $ 1.3 | $ 1.3 |
| X | ||||||||||
- Definition Amount of cash received during the period related to a research and development arrangement accounted for as a contract to perform research and development for others. No definition available.
|
| X | ||||||||||
- Definition The amount due to the entity, as of the balance sheet date, related to a research and development arrangement accounted for as a contract to perform research and development for others. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|